Vanda Pharmaceuticals | VNDA - Stock


Vanda Pharmaceuticals reported $1.85M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 108.67M 77.1M Jun/2026
Agios Pharmaceuticals USD 35.75M 665K Jun/2026
Akebia Therapeutics USD 13.02M 22K Jun/2026
Alnylam Pharmaceuticals USD 97.11M 103.04M Jun/2026
Anika Therapeutics USD 28.56M 5.73M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
AstraZeneca USD 6.93B 362M Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Halozyme Therapeutics USD 137.14M 18.33M Jun/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 142.38M 9.48M Jun/2026
J&J USD 15.14B 561M Jun/2026
Lexicon Pharmaceuticals USD 276K 5K Mar/2026
Ligand Pharmaceuticals USD 10.26M 3M Jun/2026
Merck USD 6.21B 272M Jun/2026
Moderna USD 280M 134M Jun/2026
Novartis USD 6.29B 135M Mar/2026
Pfizer USD 9.94B 722M Jun/2026
PTC Therapeutics USD 91.35M 15.79M Jun/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Sanofi EUR 24.12B 620M Jun/2026
Takeda JPY 1.45T 50.64B Jun/2026
Teva Pharmaceutical Industries USD 3.18B 3M Mar/2026
Ultragenyx Pharmaceutical USD 59M 4M Jun/2026
Vanda Pharmaceuticals USD 1.85M 190K Dec/2025
Veracyte USD 22.66M 1.24M Jun/2026